drugset / Trial / NCT02889627

Fecal Microbiota Transplantation for Epilepsy

NCT02889627 ↗

NaSingle-groupOpen-labelTreatment

Summary

Increasing evidences showed the microbiota effects on neuropsychiatric disorders. This clinical trial aims to evaluate the efficacy and safety of fecal microbiota transplantation for epilepsy.

Timeline

Start
2016-11
Primary completion
2025-10
Completion
2025-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Fecal microbiota suspension Unknown 50 ml Other

Indications